Use of pleuromutilins for the treatment of disorders caused by

Assignee: Nabriva Therapeutics AG

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 7,790,749
App. No.: 10/510,532
Granted: Sep 7, 2010
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

A method of preventing or treating diseases mediated by Helicobacter pylori , comprising administering to a subject in need of such treatment an effective amount of pleuromutilin.

Claims (5)

1. A method influencing the activity of Helicobacter pylori , comprising treating Helicobacter pylori with an effective amount of a pleuromutilin.

2. The method according to claim 1 , wherein the pleuromutilin is selected from the group consisting of a pleuromutilin of formula

a pleuromutilin of formula

and a pleuromutilin of formula

3. The method according to claim 1 , wherein the activity of Helicobacter pylori is decreased.

Assignments (8)

NUNC PRO TUNC ASSIGNMENT Recorded Apr 3, 2025

From: NABRIVA THERAPEUTICS GMBH

To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.

Reel/Frame 070725/0291 →

CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA AND THE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED AT REEL: 062881 FRAME: 0090. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Jun 20, 2023

From: HERCULES CAPITAL, INC.

To: NABRIVA THERAPEUTICS GMBH

Reel/Frame 064312/0350 →

RELEASE OF SECURITY INTEREST Recorded Mar 3, 2023

From: HERCULES CAPITAL, INC.

To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.

Reel/Frame 062881/0090 →

INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 20, 2018

From: NABRIVA THERAPEUTICS GMBH

To: HERCULES CAPITAL, INC.

Reel/Frame 047973/0110 →

RELEASE OF SECURITY INTEREST Recorded Jan 11, 2016